HIP _C_Project Energy 2013()_.indb

NANJING SINOLIFE UNITED COMPANY LIMITED 南京中生聯合股份有限公司 NANJING SINOLIFE UNITED COMPANY LIMITED 南京中生聯合股份有限公司於中華人民共和國註冊成立的股份有限公司股份代號 : 3332 NANJING SINOLIFE UNITED COMPANY LIMITED 南京中生聯合股份有限公司全球發售獨家全球協調人獨家賬簿管理人獨家牽頭經辦人及獨家保薦人 Sinolife_Cover_B10.indd 1 * 僅供識別 * 僅供識別 * 僅供識別 24/12/2013 10:01 AM

NANJING SINOLIFE UNITED COMPANY LIMITED * : 203,800,000 H : 20,380,000 H : 183,420,000 H : H 2.00 1% 0.003%0.005% : H0.10 : 3332 32342C 2014 1 9 2014 1 132.001.50 2.00 1% 0.003%0.005% 2.00 1.502.00 www.hkexnews.hk www.zs-united.com H8 S * 2013 12 31

(1) (2)...................... 2014 1 811 45........... 2014 1 812 (3)...... 2014 1 812 www.eipo.com.hk eipo (4)............... 2014 1 811 30 eipo.............. 2014 1 812.......................... 2014 1 812 (5)........................................ 2014 1 9 www.hkexnews.hk www.zs-united.com................ 2014 1 14 11. www.iporesults.com.hk.............. 2014 1 14 i

(1) H (6).... 2014 1 14 H............... 2014 1 159 (1) (2) 2014 1 89 12 (3) (4) 11 30www.eipo.com.hk 11 30 12 (5) 2014 1 92014 1 13 2014 1 13 (6) 1,000,000 2014 1 14 H 9 1H 183 17 1712-1716H HH H H ii

(1) H HH H iii

571V 2013 12 9H H H H iv

HH H H H H H H HH HHH (a) (b) (c) HH (d) v

H H H H HH HH 2013 12 16 0.78841.001.007.7533 vi

........................................................ i.......................................................... iv.............................................................. 1.............................................................. 20.......................................................... 33........................................................ 37.......................................................... 39............................................... 63...................................... 66.......................................................... 71.......................................................... 73.......................................................... 84........................................................ 98.............................................................. 112....................................... 180................................................... 192...................................................... 196.............................................................. 199.............................. 202.......................................................... 204............................................. 248........................................................ 251.............................................................. 253.................................................... 266........................................... 273............................................. I-1................................... II-1............................................... III-1............................................. IV-1..................................... V-1........................................... VI-1......................................... VII-1............................ VIII-1 vii

H H H 2012 5,800 2013 6 30 49 2012 Q10 Q10 67.1% 7.1 1

2001 2009 27 10 2013 6 30 14 10 Conbair CoKanga24 231 12 31 6 30 2010 2011 2012 2012 2013.......... 48,410 61,332 95,744 38,547 36,635............ 41,399 55,147 88,843 35,802 33,563.......... 85.5% 89.9% 92.8% 92.9% 91.6%.......... 16,922 40,837 52,613 25,505 45,537............ 11,570 27,849 40,782 18,909 38,711.......... 68.4% 68.2% 77.5% 74.1% 85.0% 2

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%) Q10. 18,107 27.1 34,504 33.4 42,179 28.0 16,489 25.4 14,969 17.4.... 1,327 1.3 24,280 16.1 12,623 19.5 2,014 2.3........ 253 0.4 574 0.6 20,076 13.4 5,063 7.8 7,391 8.6........ 483 0.7 4,751 4.6 3,526 2.4 1,405 2.2 9,443 11.0 (1).......... 29,567 44.2 20,176 19.5 5,683 3.8 2,967 4.6 2,818 3.3............ 48,410 72.4 61,332 59.4 95,744 63.7 38,547 59.5 36,635 42.6.... 1,641 2.5 7,673 7.4 22,399 14.9 11,279 17.4 13,504 15.7...... 3,980 3.9 10,311 6.8 6,600 10.2 10,312 12.0.... 627 0.9 463 0.4 557 0.4 128 0.2 25...... 2,127 3.2 6,767 6.6 5,276 3.5 931 1.4 5,339 6.2 DHA.... 17 4,450 5.2...... 3,533 5.3 7,076 6.9 1,662 1.1 937 1.4 712 0.8.... 3,680 5.5 5,766 5.6 1,323 0.9 622 1.0 860 1.0 (2).......... 5,314 7.9 9,112 8.8 11,068 7.4 5,008 7.7 10,335 12.1............ 16,922 25.3 40,837 39.6 52,613 35.0 25,505 39.3 45,537 53.0 (3).......... 1,518 2.3 1,075 1.0 2,015 1.3 767 1.2 3,793 4.4............ 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) D (2) Omega-3DHA (3) 3

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%) (1)... 41,174 61.6 57,485 55.7 93,001 61.8 37,176 57.4 35,400 41.2 (2)... 7,236 10.8 3,847 3.7 2,743 1.8 1,371 2.1 1,235 1.4.. 16,922 25.3 40,837 39.6 52,613 35.1 25,505 39.3 45,537 53.0 (3).......... 1,518 2.3 1,075 1.0 2,015 1.3 767 1.2 3,793 4.4............ 25,676 38.4 45,759 44.3 57,371 38.2 27,643 42.6 50,565 58.8............ 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) (2) (3) 4

2013 6 308 25 35 20 13 2 14 2013 5 http://conbair.tmall.com 12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%)...... 62,589 93.6 98,898 95.8 146,055 97.1 63,331 97.7 82,722 96.2.... 1,598 1.1 12 2,878 3.4............ 62,589 93.6 98,898 95.8 147,653 98.2 63,343 97.7 85,600 99.6............ 4,261 6.4 4,346 4.2 2,719 1.8 1,476 2.3 365 0.4 (1).......... 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) 2013 52013 6 30 5

2013 6 3035 7 22 2010............................... 13 15 2011............................... 15 24 2012............................... 24 34 2013 6 30............. 34 35 12 31 6 30 2010 2011 2012 2013............... 9 15 19 20............... 2 2 7 7............... 2 2 3 3............... 1 1 1 1............... 0 1 1 1............... 0 1 1 1............... 1 2 2 2 2012 62013 6 301314 2012 6 30 2012 12 31 2013 6 30.......................... 1 5 9.......................... 0 0 1.......................... 0 0 1.......................... 0 0 2.......................... 0 0 1 6

201020112012 12 312013 6 30 0.90.2 0.50.1 (i)(ii) (iii)2015 800,000650,0002,000,000 100.0 (i) (ii) 10202015 4.7 2015 7

12 31 6 30 2010 2011 2012 2012 2013......... 13.3 13.3 13.3 6.7 6.7........... 1.6 6.5 5.0 1.1 0.6 (1)............ 12.0% 48.9% 37.6% 16.4% 9.0%......... 134.4 134.4 134.4 67.2 67.2........... 58.1 23.2 18.1 8.2 7.5 (1)............ 43.2% 17.3% 13.5% 12.2% 11.2% (1) 250 GMP 250 20112010 2011Q10 20122013 2013 6 30 390,000 8

17 201020112012 12 312013 6 30 4.012.8 9.42.5 9 GMP Pharmaceuticals Pty Ltd. TGA 20142016 5% 9

65.0% 2013 5 22 10.0%7.5% 2013 6 30 86.9% 34.5% 201020112012 12 312013 6 30 93.1% 90.8% 91.6% 88.6% 11

20062011 (i)q10 (ii)q10 (iii) Q10(iv) (v) 2006 Q10 2011 120102005 Q102013 10 18 12

12 31 6 30 2010 2011 2012 2012 2013............... 66,850 103,244 150,372 64,819 85,965............. (13,588) (20,080) (20,276) (9,881) (11,264)................. 53,262 83,164 130,096 54,938 74,701....... 20,995 47,207 76,912 34,433 40,278........... (5,207) (12,393) (19,675) (8,265) (10,578)......... 15,788 34,814 57,237 26,168 29,700........... 75 (108) (11) (412)........... 15,863 34,706 57,226 26,168 29,288....... 0.29 0.63 1.04 0.48 0.53 13

12 31 6 30 2010 2011 2012 2013............ 25,037 24,338 28,204 28,494.............. 45,970 89,558 111,427 164,634................ 71,007 113,896 139,631 193,128.............. 10,520 18,703 20,118 20,327.............. 60,487 95,193 119,513 172,801.......... 71,007 113,896 139,631 193,128 6 30 12 31 12 31 6 30 2010 2011 2012 2013........ (1) 4.4 4.8 5.5 8.1........ (2) 3.9 4.2 4.9 7.6.... (3).... (4)...... (5) (1) = (2) = (3) = (4) = (5) = 14

2013 10 31 2013 10 31 66.36.459.9 2013 10 31 90.3%2013 10 31 2013 10 31 2013 6 30 2013 6 30 2013 10 31................................. 9,962 4,248....................... 339 330 (1)...................... 3,849 2,308................................. 4,188 2,638 (1) 15

2013 6 302.0 2013 6 302013 6 30 31.713.8 17.9 (i) H203,800,000(ii) 814,911,000 H 1.50 H 2.00.. 1,222.4 1,630.0 (1)............ 0.62 0.74 (1) H 1.75 333.9 16

43%143.6 31%103.6 800,000650,0002,000,000 6%20.0 6%20.0 34%113.5 23%76.8 6%20.0 3%10.0 2%6.7 Q10 Q10 17

18%60.1 6%20.02014 2014 4572 12%40.120152016 201520162080 5%16.7 201020112012 12 31 2013 6 306.0 35.026.0 30% 18

13 15 32 2013 9 2012 122013 6 30 0.1% Conbair 2013 12 31 2013 6 30 2013 6 30 13.8 2013 12 31 19

AQIS Australian Quarantine and Inspection Service 2013 9 3 2008 4 9 20

2008 4 22 2011 4 6 Cobayer Health Food Company Australia Cobayer Health Food Co Pty Ltd. 2009 3 2 21

Conbair Cokanga Cobayer Health Food Company2013 9 2 32 1999 5 24 2013 12 21 0.10 22

2007 3 16 2008 1 1 eipo 2008 6 27 H H 0.10 2008 4 2 23

20,380,000 H 1% 0.005% 0.003% 20,380,000 H 2013 12 30 24

183,420,000 H H 2014 1 9 2008 4 30 2013 12 23 H 2014 1 15 25

1994 8 27 2011 7 15 2013 7 1 26

2003 6 17 2005 3 2 90% 10%2011 7 27 1% 0.003% 0.005% H H 27

30 30,570,000 H 2005 10 27 2006 1 1 2014 1 9 2014 1 13 28

2011 6 24 S S 571 2011 4 18 2013 3 31 2013 7 31 2013 11 18 0.10 29

2009 4 23 2011 3 1 2 45 1 6 1994 8 4 30

2008 3 26 TGA Therapeutic Goods Administration 201020112012 12 31 2013 6 30 1933 eipo eipowww.eipo.com.hk eipo 31

2011 5 23 2008 4 10 2011 4 28 2012 6 27 ( )( )( ) * 32

- 9,12,15- Omega-3 5--3- - D 33

Q10 GMP (Good Manufacturing Practice) 27 34

Omega-3 60%- 10 35

E 36

H H 2010 66.9 2011 103.22012 150.4 20102012 49.9% 201013 2013 6 30 8 253514 20144572 39

201020112012 12 31 2013 6 30 79.7% 80.6% 86.5% 86.9%201020112012 12 312013 6 30 23.6% 33.7% 38.1% 34.5% 72.0 800,000650,0002,000,000 2015 100.0 40

10 202015 4.7 2015 Q10 2012 6 30 16.5201315.0 2012 6 30 12.620132.0 41

201020112012 12 312013 6 30 74.8% 67.7% 61.3% 55.9% 93.1% 90.8% 91.6% 88.6% 201020112012 12 31 2013 6 30 70.1% 87.8% 94.5% 82.9% 42

2013 8 13 44

2013 9 45

2010 20112012 12 312013 6 30 1.1 1.43.93.0 46

2014 12 312015 12 31 2014 12 31 2013 5 13 47

20062011 (i) Q10 (ii) Q10(iii) Q10(iv) (v) 2006 Q10 48

2010 2010 Q10Q10 1.0 49

18% 25%8,00054,000 16% 27% 51

15 60 14 52

20112012 1.0 1.52012 6 302013 0.6 1.0 53

441 3,986.4 44 10 859.6 21.6% 44 9 54

Q10Q10 1.0 55

30 2008 56

20142016 1994 19942005 7 10 2005 7 21 H 57

HH H 58

20% 10% 10%(i)10% (ii)10% 20% (iii)20% H10% 2008 11 6H [2008]897 H10% H H H H H H 2070 59

20092013 60

HH HH H HH H H H H HHHH HH H 61

H HH H 62

8.1219A.15 8.1219A.15 8.1219A.15 (a) 3.05 (b) (i) 63

(ii) (c) 3A.19 13.46 (d) (e) (f) 3.288.17 (i)(ii)159 (iii)50 (i) (ii) 64

(iii) 3.29(iv) 3.28 3.288.17 3 3.28 8.17 3.28 3.28 8.173 3 3 3.288.17 33.288.17 65

69 42 23 2703 49 13202 7 2601 66

220 28 101 51 11205 19 13-603 FCPA (Australia), FCPA (HK), FCIS, FTI (HK) 1 32 F 67

438 12 1 302 99 8 601 32 702 15 501 102 68

68 9 68 9 1 40 222 13 Longton Legal Suite 903, Level 9 370 Pitt Street, Sydney NSW 2000 Australia Bell Gully Vero Centre 48 Shortland Street Auckland New Zealand 69

15 33 77 334 111 25 6-8 33 20 70

71 188 30 1 40 www.zs-united.com 188 30 FCS (PE), FCIS 183 54 69 42 183 54

169 28 H 183 17 1712-1716 482 2-16 72

73 1970 30 2008201231.4 51.923,70838,449 13.4% 12.8% 20082012 2008 100 80 60 40 20 0 50,000 40,000 30,000 20,000 10,000 0 31.4 23,708 25,608 30,015 35,198 38,449 34.1 40.2 47.3 51.9 2009 2010 2011 2012

2008 15,7812012 24,56511.7% 2008 4,7612012 7,919 13.6% 20082012 25,000 20,000 15,000 15,781 17,175 19,109 21,810 24,565 10,000 5,000 4,761 5,153 5,919 6,977 7,919 0 2008 2009 2010 2011 2012 2012 74

2012 50,000 45,000 40,188 40,000 35,000 30,000 26,253 25,000 20,000 15,000 10,000 5,000 0 36,469 24,046 34,550 21,545 30,227 22,396 29,677 18,825 29,626 20,024 24,565 16,674 2012 201273.7 602012 6014.3% 20082012 100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% 12.0% 12.5% 13.3% 13.7% 14.3% 69.0% 69.0% 70.1% 69.8% 69.2% 19.0% 18.5% 16.6% 16.5% 16.5% 2008 2009 2010 2011 2012 0-14 15-59 60 75

76 2012 12 31 12,3142012 12 31 2012 48 32 27 25 24 20 15 12 9 3 0 10 20 30 40 50 60

2008 2,6502012 5,800 21.6% 20122015 20.5%201510,150 1,400 1,200 22.6% 23.1% 21.3% 19.6% 20.7% 20.7% 20.1% 24% 20% 1,000 16% 800 600 400 200 265 325 400 485 580 700 845 1,015 12% 8% 4% 0 2008 2009 2010 2011 2012 2013 2014 2015 0 2008201221.0% 77

20082012 2008 2009 2010 2011 2012... 81.9% 81.3% 81.0% 81.0% 81.0% (1)............... 9.1% 9.2% 9.3% 9.3% 9.5% (2)............. 1.5% 1.5% 1.5% 1.5% 1.6%............. 0.6% 0.8% 1.0% 1.2% 1.4%................ 7.0% 7.2% 7.3% 7.0% 6.6% (1) (2) 2012 12 31 2012 2010 2012 2012 (1) 1 104 380 9.0% 3.7 2 Fancl 140 350 32.3% 2.5 3 DHC Co., Ltd. 590 200 41.4% 0.3 4 210 180 22.5% 0.9 5 39 150 50.0% 3.9 (1) 78

GNC Holdings, Inc. NBTY, Inc. 201210,000 201224,565 7,919 2010 22020 4.56 79

3,000 2010 4,200 70% 75% 602012 1.94 14.3%2020 60 2.6118.0% 80

Q10 Q10 Q102010 302012 6320102012 44.5%2015153 20122015 34.4% Q10 2010 2011 2012 2010 2012 1 (1)............................ 18 59.4% 35 67.0% 42 67.1% 52.8% 2 (2)............... 4 13.3% 5 9.7% 6 9.5% 22.5% 3............. 4 13.3% 4 8.3% 5 7.6% 11.8% (1) Q10Q10Q10 (2) 2010 303 2012 4442010201220.9% 2015839 20122015 23.6% 81

2010 2011 2012 2010 2012 1.......................... 77 25.4% 95 26.7% 120 27.1% 24.8% 2............... 65 21.4% 75 21.1% 88 19.8% 16.4% 3........... 50 16.5% 55 15.5% 60 13.5% 9.5% 4........... 20 6.6% 23 6.5% 25 5.6% 11.8% 5 (1)............................ 0.3 0.1% 1 0.2% 20 4.5% 1,314.2% (1) 2010 1812012 29420102012 27.3%2015578 20122015 25.3% 2010 2011 2012 2010 2012 1............. 43 23.7% 53 23.5% 65 22.1% 22.9% 2............. 45 24.8% 50 22.1% 60 20.4% 15.5% 3......... 40 22.3% 46 20.4% 52 17.7% 14.0% 4............. 28 15.4% 43 19.0% 50 17.0% 33.6% 5 (1)............................ 1 0.6% 24 8.3% (1) 82

1979 600,000 83

2009 6 1 1995 10 30 2009 6 12009 2 28 2009 6 1 2009 7 20 2009 6 1 2009 6 1 2005 7 9 2005 9 1 84

2005 9 1 2009 7 30 2005 4 30 2005 7 1 1996 3 15(i) (ii) 85

2005 7 1 2005 7 1 2010 7 23 87

GMP 1998 5 5 1999 1 1 2003 4 2 GMPGMP 2008 2 2 GMP GMPGMP 2009 6 10 2009 6 1 2009 7 20 2011 9 13 2012 3 1 88

1989 12 26 1984 5 11 2008 2 281987 9 5 1995 8 292000 4 29 1995 10 30 2004 12 29 89

1994 10 27 1995 2 1 1987 10 26 1987 12 1 1998 12 3 2005 5 24 2005 7 1 2009 7 30 2009 9 8 2010 1 1 90

2007 10 16 2008 1 1 1993 2 222000 7 82009 8 27 1993 10 31 1994 1 1 2009 12 26 2010 7 1 91

1982 8 23 1983 3 11993 2 222001 10 27 2002 8 3 2002 9 15 2008 12 27 1994 7 5 1995 1 1 2008 1 1 2012 12 28 2002 6 29 2002 11 1 2009 8 27 92

2010 10 28 2011 7 1 1999 4 32002 3 24 AQISAQIS FSANZ AQIS1982Export Control Act 1982 AQIS DAFF Office of Legislative Drafting Attorney-General s Department ZDCN02 ZDCN01 ZD001 93

ZD015 ZD016 AQISAQIS AQIS Office of Legislative Drafting and Publishing, Attorney-General s Department 2007 10 122005 Export Control (Milk and Milk Product) Order 2005 3.1 3.2 2007 1(Export Control (Milk and Milk Products) Amendment Order 2007 (No. 1))20052005 (a) (b) (c) (d) (e) 1991Food Standards Australia New Zealand Act 19913Australia New Zealand Food Standards Code 2005 CRISs DAFF2009 7 1 Import Clearance Program and Seaports Program CRISs2005 Australian Government Cost Recovery Guidelines (2005) DAFF 94

AQIS HACCP AQIS 2009a Export Control (Meat and Meat Products) Orders 2005AQIS AQIS Australian Meat and Live-Stock Industry Act 1997 MPI 1981 (Food Act 1981) 1984Food Regulations 1984 2002Australia New Zealand Food Standards Code 2002 1981Food Act 19812003(Wine Act 2003) 1999Animal Products Act 1999 MPI 95

MPI MPI MPI Overseas Market Access Requirements OMARs MPI Approved Premises Notice 1999Animal Products Act 19991999Animal Products Act 1999 1999 Animal Products Act 1999 MPI MPI 96

MPI RMPRMP MPI MPI RMP RMP 300,000 50,0001999(Animal Products Act 1999)RMP 100,000 25,000 97

1999 5 1999 11 10.00% 78.00% 8.67% 2001 20032005 2005 2007 210,200,000 51.00% 9.18% 5.10% 5.10% 4.08% 27.54% 2008 59,800,000 49.00% 2007 11 14Q10 2008 6Q10 20122008 2009 98

2009 3Cobayer Health Food Company 2009 8 2012 6 2013 6 3014 2011 7 2012 9 27 1,840,0002012 8 31 2012 9 27 99

2012 6 27 2012 7 2 26,000,00027,000,000 6,193,7001,000,0002012 7 13 (%) (1) 2013 6 30 (%) 2,017,200 32.43% 2,008,509 1.080% 1,681,000 27.02% 1,673,758 0.900% 201,800 3.24% 200,931 0.108% 201,800 3.24% 200,931 0.108% 201,800 3.24% 200,931 0.108% 201,800 3.24% 200,931 0.108% 201,800 3.24% 200,931 0.108% 201,800 3.24% 200,931 0.108% 201,800 3.24% 200,931 0.108% 168,100 2.71% 167,376 0.090% 168,100 2.71% 167,376 0.090% 168,100 2.71% 167,376 0.090% 134,500 2.17% 133,921 0.072% 134,500 2.17% 133,921 0.072% 84,100 1.35% 83,738 0.045% 84,100 1.35% 83,738 0.045% 84,100 1.35% 83,738 0.045% 84,100 1.35% 83,738 0.045% 6,220,500 100% 6,193,700 (1) 3.33% (1) Cobayer Health Food Company 2012 8 28 Cobayer Health Food Company2,000 100

4,100,000 Cobayer Health Food Company 2012 12 24 Cobayer Health Food Company 2013 11 1918 2012 7 2 2013 11 2618 18 (1) 2013 6 30 (%) 2,008,631 1.080% 659,955 1,673,538 0.900% 549,857 200,676 0.108% 65,934 200,676 0.108% 65,934 200,676 0.108% 65,934 200,676 0.108% 65,934 200,676 0.108% 65,934 200,676 0.108% 65,934 200,676 0.108% 65,934 167,848 0.090% 55,148 167,848 0.090% 55,148 167,848 0.090% 55,148 134,402 0.072% 44,159 134,402 0.072% 44,159 83,613 0.045% 27,472 83,613 0.045% 27,472 83,613 0.045% 27,472 83,613 0.045% 27,472 6,193,700 (1) 3.33% 2,035,000 (1) 101

1999 5 2007 2 51% 2007 11 Q10 2008 5 49% 2009 3 Cobayer Health Food Company 2009 8 2009 10 2010 12 31 15 2011 12 31 24 2012 2 2012 6 102

2012 8 Q10 2012 9 2012 12 Cobayer Health Food Company Cobayer Health Food Company 2012 12 31 5 34 2013 5 http://tmall.taobao.com 2013 6 30 14 35 103

104 15 1999 5 24 61,111,100 2003 6 17 20,000,000 2008 3 26 600,000 2008 4 2 600,000 2008 4 9 600,000 2008 4 10 600,000 2008 4 22 600,000 2008 4 30 600,000 2008 6 27 600,000 Cobayer Health Food Company 2009 3 2 2,000

2009 4 23 600,000 2011 4 6 500,000 2011 4 28 100,000 2011 5 23 100,000 2011 6 24 100,000 2011 7 15 1,000,000 2013 11 18 100,000 105

(1) (2) 2013 3 31 50,000,000 2013 (1) 30.7% 48.0% 7.50% 2013 7 31 5 22 (2) 0.82 (3) (1) 2.00 1.50 (2) 2013 3 31 2013 7 31 506,111,100 (1) 2016 12 31 (2) 106

(3) 2013 30% (4) (i) (a) 120 (i) (ii) (iii) (b) 10 (c) 10 (d) 30 (ii) 10 (iii) (iv) 107

(v) (vi) (5) (6) 10 30 (7) 2013 5 22 108

8.08(1) 16484200 61,111,0007.50% 2013 5 2228 109

2013 5 15.9 (i)0.6 6.4(ii)0.6 (iii) 8.3 78.00% 8.67% 3.33% 10% 100% Cobayer Health Food Company 110

58.50% 6.50% 2.50% 7.50% 25.00% 100% Cobayer Health Food Company (1) (%) (%) 1.080% 0.811% 0.900% 0.676% 0.108% 0.081% 0.108% 0.081% 0.108% 0.081% 0.108% 0.081% 0.108% 0.081% 0.108% 0.081% 0.108% 0.081% 0.090% 0.068% 0.090% 0.068% 0.090% 0.068% 0.072% 0.054% 0.072% 0.054% 0.045% 0.034% 0.045% 0.034% 0.045% 0.034% 0.045% 0.034% 3.330% 2.502% 111

2012 5,800 2013 6 30 49 2012 Q10 Q10 67.1% 7.1 2001 2009 27 10 112

2013 6 30 14 10 Conbair CoKanga24 231 2013 6 30 825 35 20 13 2 14 2013 5 http://conbair.tmall.com 113

2010201266.9 150.4 15.8 57.2 49.9% 90.3% 17.3% 2012 6 30 64.8 32.7%2013 6 30 86.0 26.2 13.4%29.7 20102012 20.4%20125,800 20132018201817,300 2008 15,7812012 24,565 11.7% 60 2012194 14.3% 2020 261 70% 114

14 2010201249.9% 90.3% 115

2012 Q10 Q1067.1% 7.1 2013 6 30825 2013 6 3022 35 13 14 116

1999 5 2010 1 1132013 6 30 35 2012 6 2012 6 3012013 6 3014 117

2013 6 3057 18% 118

2013 6 30381424 14 2007 11 Q10 2012 Q10 Q1067.1% 7.1Q102012 Q10 5 3 7 119

14 2014 4520152016 20 80410,000 120

2014 2016 (1) 2014 1 3.7 2 0.8 2015 1 1.6 3 2.5 2016 1 2 1.6 2.5 31 12.7 (1) 410,000 201472 2015201680 30220,000 2013 5 http://conbair.tmall.com 121

20142016 (1) 2014 1 1.5 2 5.7 3 2.0 2015 1 0.2 2 3.5 3 3.3 4 1.8 2016 1 0.4 2 3.5 3 2.6 5 2.2 122 26.7 (1) 220,000 122

2013 6 30930 2015 800,000650,0002,000,000 123

2014 200 5 2016 25 7 124

(1) (3) (2) (3) (3) (4) (5) (7) (8) (6) (3)(4) (1) (2) (3) (4) (5) Conbair CoKanga (6) (7) (8) 2013 5 125

(i) (ii)conbair CoKanga 201020112012 12 31 2013 6 30 12 31 6 30 2010 2011 2012 2012 2013........... 48,410 61,332 95,744 38,547 36,635............. 41,399 55,147 88,843 35,802 33,563........... 85.5% 89.9% 92.8% 92.9% 91.6%........... 16,922 40,837 52,613 25,505 45,537............. 11,570 27,849 40,782 18,909 38,711........... 68.4% 68.2% 77.5% 74.1% 85.0% 126

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%) Q10...... 18,107 27.1 34,504 33.4 42,179 28.0 16,489 25.4 14,969 17.4......... 1,327 1.3 24,280 16.1 12,623 19.5 2,014 2.3............. 253 0.4 574 0.6 20,076 13.4 5,063 7.8 7,391 8.6............. 483 0.7 4,751 4.6 3,526 2.4 1,405 2.2 9,443 11.0 (1)............... 29,567 44.2 20,176 19.5 5,683 3.8 2,967 4.6 2,818 3.3................. 48,410 72.4 61,332 59.4 95,744 63.7 38,547 59.5 36,635 42.6......... 1,641 2.5 7,673 7.4 22,399 14.9 11,279 17.4 13,504 15.7........... 3,980 3.9 10,311 6.8 6,600 10.2 10,312 12.0......... 627 0.9 463 0.4 557 0.4 128 0.2 25........... 2,127 3.2 6,767 6.6 5,276 3.5 931 1.4 5,339 6.2 DHA......... 17 4,450 5.2........... 3,533 5.3 7,076 6.9 1,662 1.1 937 1.4 712 0.8......... 3,680 5.5 5,766 5.6 1,323 0.9 622 1.0 860 1.0 (2)............... 5,314 7.9 9,112 8.8 11,068 7.4 5,008 7.7 10,335 12.1................. 16,922 25.3 40,837 39.6 52,613 35.0 25,505 39.3 45,537 53.0 (3)............... 1,518 2.3 1,075 1.0 2,015 1.3 767 1.2 3,793 4.4................. 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) D (2) Omega-3DHA (3) 127

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%) (1)......... 41,174 61.6 57,485 55.7 93,001 61.8 37,176 57.4 35,400 41.2 (2)......... 7,236 10.8 3,847 3.7 2,743 1.8 1,371 2.1 1,235 1.4........ 16,922 25.3 40,837 39.6 52,613 35.1 25,505 39.3 45,537 53.0 (3)................ 1,518 2.3 1,075 1.0 2,015 1.3 767 1.2 3,793 4.4.................. 25,676 38.4 45,759 44.3 57,371 38.2 27,643 42.6 50,565 58.8.................. 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) (2) (3) 28 18 2001 Q10 128

業務輔酶Q 10片膠囊我們的輔酶Q10片膠囊的作用是幫助緩解身體疲勞我們的輔酶Q10片膠囊於 2007年11月經國家食品藥品監督管理總局批准為保健食品其中輔酶Q10膠囊於2012年 8月經江蘇省科技廳進一步認定為高新技術產品我們分別自2008年6月及2011年10 月起以中生品牌製造及銷售輔酶Q10膠囊及輔酶Q10片現已就這兩款產品投保了總額為人民幣1.0百萬元的一年期產品責任險於截至2010年 2011年及2012年12月31日止年度以及截至2013年6月30日止六個月我們銷售輔酶Q10片膠囊產生的營業額分別為人民幣18.1百萬元人民幣34.5百萬元人民幣42.2百萬元及人民幣15.0百萬元分別佔我們同期總營業額的27.1% 33.4% 28.0%及17.4% 往績記錄期間輔酶Q10片膠囊的平均售價介乎每瓶人民幣232.5元至人民幣388.9元之間我們的輔酶Q10片膠囊主要含輔酶Q10 乳糖及微晶纖維素我們不參與輔酶Q10 我們輔酶Q10片膠囊生產過程中的主要原材料的發酵過程而是向第三方供應商採購經酵輔酶Q10 每100.0克輔酶Q10片膠囊含3.3克輔酶Q10 我們的輔酶Q10片膠囊的形式為片劑和硬膠囊劑並以每瓶120片每瓶30粒膠囊及每瓶90粒膠囊的包裝銷售我們輔酶Q10片膠囊的貨架期為24個月亞麻酸軟膠囊我們的亞麻酸軟膠囊的作用是幫助降低血脂其於2011年1月經國家食品藥品監督管理總局批准為保健食品我們自2011年10月起以中生品牌製造及銷售該產品截至2011年及2012年12月31日止年度以及截至2013年6月30日止六個月我們銷售亞麻酸軟膠囊產生的營業額分別為人民幣1.3百萬元人民幣24.3百萬元及人民幣2.0百萬元分別佔我們同期總營業額的1.3% 16.1%及2.3% 往績記錄期間亞麻酸軟膠囊的平均售價介乎每瓶人民幣167.8元至人民幣324.4元之間 129

E 100.0 45.0 120 24 2006 8 2010 82007 82010 20112012 12 312013 6 30 0.30.620.1 7.40.4% 0.6% 13.4% 8.6% 32.6 941.7 100.0 6.910.0 9012024 2002 1 2005 6 2006 720102011 130

2012 12 312013 6 30 0.54.83.59.4 0.7% 4.6% 2.4% 11.0% 155.2 311.0 100.070 6090 24 Q10 2313 24 36 201020112012 12 312013 6 30 Q10 29.620.25.72.8 44.2% 19.5% 3.8% 3.3% Conbair CoKanga27 2009 8 274.4 473.3 205.8 451.9 172.0 288.1 193.1 491.4 308.4 766.8 131

201020112012 12 312013 6 30 16.940.8 52.645.525.3% 39.6% 35.0% 53.0%Conbair CoKanga 2013 6 30 (1) 2010 1 2010 3 2010 3 2010 3 132

(1) 2010 3 2010 6 2010 11 2011 1 2011 9 2011 10 2011 10 Omega-3 2011 12 2012 1 2012 4 2012 5 DHA 2012 12 DHA E 2013 3 (1) (i) Conbair (ii)dha (iii) CoKanga 133

201020112012 12 312013 6 30 1.51.12.0 3.82.3% 1.0% 1.3% 4.4% 2014 2014 134

2016 25 2014 2015 2014 2015 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 135

2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 2015 2016 136

2016 2013 6 30 2014 2015 137

2014 2015 2015 2016 2015 2016 2015 2016 2015 2016 2016 2017 2016 2017 2014 2014 2014 2014 2014 2014 2014 138

........................ 2013 1 15 2014 6 30...................... 2013 1 15 2014 6 30........................ 2011 6 20 2014 6 19...................... 2010 11 4 2016 11 3 (HACCP).. 2012 10 26 2015 10 25 ISO 9001:2008................. 2012 10 24 2015 10 23 ISO 22000:2005................ 2012 10 26 2015 10 25 139

(1) 1. Q10............ 2007 11 14 2018 8 18 1 2. Q10........... 2007 11 14 2018 4 11 1 3.......... 2011 1 28 2016 1 27 0 4. (2)............ 2006 8 1 (3) 2018 7 15 1 5.............. 2005 1 24 (4) 6........ 2001 11 14 (4) 7.............. 2002 1 22 (5) (4) 8............ 2008 4 18 2013 4 17 (6)(7) 0 9. (8)........ 2006 6 23 (3) 2018 9 22 1 10. (8)............ 1998 1 13 (3) (4) 11. (9).......... 2006 8 29 2018 4 11 1 12. (8)............ 2000 3 27 (3) (4) 13. D......... 2007 9 21 2018 9 2 1 14. (8)............ 2004 6 24 (4) 15. (8)........ 2001 12 10 (3) (4) 16. (8)............ 2006 3 28 2018 9 2 1 17. (8)........ 1999 7 7 (3) (4) 140

1.......... 2004 4 15 (4) 2.............. 2002 10 31 (3) (4) 3.......... 2004 1 16 (4) 4....... 2004 1 16 (4) 5............ 2002 9 20 (4) 1.................... 2007 7 25 2012 7 24 (6)(10) 0 2.................... 2007 7 25 2018 9 4 1 3.................... 2007 7 25 2018 9 22 1 4.................... 2007 7 25 2018 9 4 1 5. D.. 2007 8 29 2018 8 8 1 (1) 2012 (2) (3) 2010 8 141

(4) 2005 7 1 2005 7 1 (5) 2005 6 (6) (7) 2013 22014 201020112012 12 312013 6 30 246,000 247,000 14,000 9,000 (8) 2013 6 30 (9) (10) 2012 42014 2010 20112012 12 312013 6 30 93.6% 95.8% 97.1% 96.2% 142

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%).... 62,589 93.6 98,898 95.8 146,055 97.1 63,331 97.7 82,722 96.2.. 1,598 1.1 12 2,878 3.4.......... 62,589 93.6 98,898 95.8 147,653 98.2 63,343 97.7 85,600 99.6.......... 4,261 6.4 4,346 4.2 2,719 1.8 1,476 2.3 365 0.4 (1)........ 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) 2013 52013 6 30 12 31 6 30 2010 2011 2012 2013 (1)........ 355.0 402.9 465.0 395.6 (2) (1)...... 133.1 60.0 (3) (1) (2) 2013 (3) 2013 2013 143

業務零售店截至2013年6月30日我們在25個城市擁有49家零售店覆蓋中國8個省份和直轄市包括35家中生零售店和14家康培爾零售店此等零售店均由我們管理下圖顯示我們截至2013年6月30日在中國的市場覆蓋覆蓋省份覆蓋城市青島: 2 北京: 1 中生零售店 :1 濟南: 2 中生零售店 :1 康培爾零售店 :1 鹽城: 1 中生零售店 :1 康培爾零售店 :1 康培爾零售店 :1 江陰: 1 鎮江: 2 中生零售店 :1 康培爾零售店 :1 中生零售店 :1 無錫: 3 常州: 3 中生零售店 :1 康培爾零售店 :2 中生零售店 :2 康培爾零售店 :1 太倉: 1 南京: 9 中生零售店中生零售店 :8 康培爾零售店 :1 昆山: 2 北京溧陽: 1 康培爾零售店濟南青島康培爾零售店鎮江 :2 :1 成都 :1 成都: 1 中生零售店 :1 康培爾零售店 :1 蘇州: 5 中生零售店 :4 康培爾零售店 :1 海寧: 1 中生零售店 :1 吳江: 1 中生零售店 :1 :1 昆明廣州昆明: 1 康培爾零售店鹽城常州江陰太倉南京無錫昆山溧陽武漢蘇州海寧杭州吳江寧波蕭山溫州紹興武漢: 1 中生零售店中生零售店 :1 杭州: 3 中生零售店 :1 深圳寧波: 1 中生零售店 :1 :1 蕭山: 1 廣州: 1 中生零售店中生零售店 :1 :1 紹興: 1 中生零售店深圳: 3 中生零售店 :2 康培爾零售店 :1 :1 溫州: 1 中生零售店 144 :1

業務中生零售店截至2013年6月30日我們以中生品牌開設35家零售店覆蓋7個省份及直轄市的 22個城市下表載列中生零售店數目於往績記錄期間的變動截至年期初截至年期末的零售店數目的零售店數目 2010年............................... 13 15 2011年............................... 15 24 2012年............................... 24 34 截至2013年6月30日止六個月............. 34 35 期間下表載列截至所示日期按地區劃分的中生零售店在中國的地理覆蓋截至12月31日地區截至6月30日 2010年 2011年 2012年 2013年江蘇................ 9 15 19 20 浙江................ 2 2 7 7 廣東................ 2 2 3 3 北京................ 1 1 1 1 湖北................ 0 1 1 1 四川................ 0 1 1 1 山東................ 1 2 2 2 145

1999 5 2013 6 3020 132 24123 20102011 2012 12 312013 6 30 62.0% 58.2% 40.2% 37.0% 801,087 20102011 2012 12 312013 6 30 30.0% 37.0% 56.8% 58.5% 146

業務百貨公司專櫃截至2013年6月30日我們在江蘇省南京市及蘇州市分別擁有面積為57平方米及15平方米的2個百貨公司專櫃有關百貨公司專櫃分別於2006年9月及2012年12月開業該等百貨公司專櫃由我們自己的僱員管理我們在未與有關百貨公司訂立任何付款結算安排的情況下向客戶直接收取付款並每季向有關百貨公司支付固定的聯營費用截至2013年6月30 日止六個月來自該等百貨公司專櫃的銷售額佔我們總營業額的0.6% 我們於江蘇省蘇州市的百貨公司專櫃於2013年9月結束營業有關詳情請參閱概要近期發展我們在各中生零售店銷售全線中生系列產品及某些精選的澳大利亞營養膳食補充劑以利用中生零售店的客戶基礎截至2010年 2011年及2012年12月31日止年度以及截至2013年6月30日止六個月在中生零售店銷售康培爾系列產品產生的營業額分別為人民幣16.9百萬元人民幣40.8百萬元人民幣51.0百萬元及人民幣42.6百萬元分別佔我們同期總營業額的25.3% 39.6% 33.9%及49.6% 隨着康培爾零售店的快速擴張我們預期將逐步減少在中生零售店銷售康培爾系列產品所有該等產品均將在我們的康培爾零售店銷售截至2013年6月30日我們就中生零售店分別租賃及擁有總建築面積為3,214.8平方米的32項零售物業及總建築面積為1,551.0平方米的3項零售物業康培爾零售店自我們於2012年6月在江蘇省南京市開辦第一家康培爾零售店以來截至2013年6 月30日我們已在13個城市合共有14家總建築面積達528.2平方米的康培爾零售店覆蓋江蘇省浙江省廣東省山東省及雲南省下表載列截至所示日期按地區劃分的康培爾零售店於中國的地理覆蓋 147

2012 6 30 2012 12 31 2013 6 30................... 1 5 9................... 0 0 1................... 0 0 1................... 0 0 2................... 0 0 1 10 16 81 5,000 100,000 (i) 8,578 45,435 (ii)18% 25%(iii) 8,000 54,00016% 27% 2012 12 312013 6 30 677,000 824,000 148

3,000 10,000 15 60 2013 6 30..... 3 126.6 20152016......... 4 121.2 20132014....... 7 280.4 20132016 201020112012 12 312013 6 30 4.34.32.70.4 6.4% 4.2% 1.8% 0.4%2013 6 30 149

2010182013 6 30 1 20101815 6 30 12 31 2010 2011 2012 2013............... 18 15 8 1............... 3 0 0 0............... (6) (7) (7) 0............... 15 8 1 1 2003 2010 20112012 12 312013 6 30 3.1% 2.0% 1.3% 0.4% 5,000 150

30 (i) (ii) 2004 42012 5 18 20,000 50,000 12 15201020112012 2.02.3 0.72012 10 30 151

2013 5http://tmall.taobao.com 152

153

15 60 154

50,000 2013 6 30 18% 155

10%15% 15% 156

2010 2010 8 17 Q10 2010 11 5 2011 2011 5 5 2012 Q10 Q10 2013 9 2 2013 9 2 2013 9 2 2013 9 2 2013 9 2 2013 9 2 2013 9 2 2013 9 25 2013 9 25 2013 1 1 (1) 2013 11 18 Q10 2014 10 16 Q10 2014 10 16 2014 11 11 2014 11 11 2014 11 13 (1) D 157

27 Q10 Q10 22 (i) (ii) (iii) 2010 12 31 7.1% 3.1%20112012 12 312013 6 30 5% 158

(1) (1) 24 48 2013 6 309 30 201020112012 12 31 2013 6 30 0.40.20.20.4 159

28,337 50% GMP (i)(ii) (iii)2015 800,000650,0002,000,000 (i) (ii)(iii) (iv) 160

2013 6 30 3,237.4 26,592.8100.0 28,337 (1)................. 72.0 2015 12............. 14.0 2015 12........ 14.0 2015 12 (1) 20142015 (i) (ii) 161

162

30 163

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%).. 1,327 1.3 8,729 24,280 16.1 88,921 12,623 19.5 39,361 2,014 2.3 4,786...... 2,952 4.4 30,218 157 0.2 2,937 95 0.1 758 18 218 0.3 2,871...... 246 0.4 1,000 247 0.2 14 0.0 122 2 9.......... 3,198 4.8 31,218 1,731 1.7 11,666 24,389 16.2 89,801 12,643 19.5 39,361 2,241 2.6 7,657...... 965 1.4 191,930 44...... 227 0.2 28,950 283 0.3.......... 965 1.4 191,930 44 227 0.2 28,950 283 0.3 (1)......... 4,163 6.2 223,148 1,775 1.7 11,666 24,616 16.4 118,751 12,643 19.5 39,361 2,524 2.9 7,657 (1) 2012 (i) 165

(ii)2012 (iii)20122012 ISO9001:2008 GMP 166

201020112012 12 312013 6 30 0.90.20.5 0.1 201020112012 12 312013 6 30 4.012.89.42.5 9 2010 34,950 167

GMP Pharmaceuticals Pty Ltd. TGA 168

5% GMP 169

2012 10ISO9001:2008 ISO22000:2005 (HACCP) ISO GMP GMP GMP 170

30 60 2012 12 3162 5201020112012 12 31 2013 6 305.7 11.611.02.9 57.8% 70.9% 74.0% 71.9%2013 6 30 GMP Pharmaceuticals Pty Ltd. 201020112012 12 312013 6 30 25.0% 28.9% 41.7% 51.1% 5% 171

(i) (ii) (iii) 7 8 4920 172

28,3373,237.4 1,747.2 173

441 3,986.4 44 10 859.6 21.6% 9 5.01A5.01B 2013 6 30 15% 174

Q10 Longton Legal Bell Gully 175

2006 2009 32011 Q10 (i) 1 13 2011 1 Q10 (ii) 2006 92009 (i) 2009 8 10 11 (ii) (iii) 176

177 2010 82010 9 2 Q10 2011 5 Q10 2012 9 (i) Q10 (ii) Q10 2009(iii) Q10 2009 13 2 2006 (i) (ii) 2005 2006 (i) (ii) (iii)

2013 10 18 (i) (ii) (i) (ii) 2013 5 12013 11 30 (i) (ii) (iii) (iv) 178

1.9 (i) (ii) Q10 (iii) (iv) (i) (ii) (iii) (iv) (v) 60 (vi) (vii) 179

8413 53 1999 5 24 1999 5 24 43 1999 5 25 2011 6 17 39 2002 1 1 2012 10 25 32 2003 7 29 2012 10 25 44 2013 5 16 2013 5 16 57 2012 10 25 2012 10 25 45 2013 1 25 2013 1 25 50 2013 8 10 2013 8 10 180

531999 5 24 Cobayer Health Food Company 1989 72010 6 EMBA 1992 111994 10 1995 11996 121997 1 1998 121999 5 432011 6 17 1.08% 1999 5 2008 1 2012 6 EMBA 392012 10 25 0.9% 2002 1 2010 12012 10 181

1999 72009 9 EMBA 322012 10 25 0.11% 2003 72008 1 2012 10 2008 1 442013 5 16 1993 7 2012 1 1993 7 1998 10Charles Darwin University Northern Territory University 572012 10 25 1986 121987 9 1996 7 1980 31987 91989 9 1994 12 182

2007 102013 10 600682 002304 452013 1 25 1989 71996 7 2002 3 1996 72003 72008 4 Geisel School of Medicine at Dartmouth Dartmouth Medical School 2009 9 FCPA(Aust) FCPA(HK) FCIS FTI(HK) 50 2013 8 10 2003 5(Deakin University) 1993 112000 122008 4 1987 122000 9 2000 10Vitapharm Research Pty Ltd 2002 2 2003 5 513 2010 7 183

5 35 2002 9 16 2012 10 25 37 2013 5 16 2013 5 16 34 2005 9 25 2012 10 25 35 2001 6 20 2012 10 25 28 2003 8 30 2013 5 16 352012 10 25 1999 6 2002 2002 92004 9 2004 92008 1 2012 10 372013 5 16 1999 7 2002 9 185

2007 8 342012 10 25 2003 6 2005 9 2010 1 2012 10 352012 10 25 2005 10 2001 62012 10 282013 5 16 2004 7 2003 8 2009 7 0.11% 0.09% 13.51(2)(a) (v) 186

32 2002 6 4 2012 10 25 60 2005 3 21 2005 3 21 33 2013 7 1 2013 7 1 29 2006 9 4 2013 9 1 322002 6 2008 12012 10 0.072% 2002 6 601992 5 1999 122005 2 2005 3 0.045% 332013 7 2003 82012 7 2003 102007 3 2007 62009 92009 102010 10 187

292013 9 2006 9 2008 82011 1 2006 6 FCS (PE), FCIS 462013 11 7 20 1990 11 2012 12 31 2013 6 30 1.31.41.8 0.92012 12 31 2013 6 30 0.70.6 188

0.40.1 12 2013 12 31 1.10.4 189

3A.19 3A.23 (1) (2) (3) 190

(4) 2013 6 30466 290 12 32 9 32 60 31 466 191

58.50% 6.50% 2.7 3.04.03.3 192

2013 9 2013 12 21 (i) (ii) (iii) 193

(iv) (v) (vi) (i) (vi) (i) H H(ii) (i) 30% (ii) H 194

(i) (ii) (iii) (iv) 195

(1) 14A.11(1) (2) 14A.11(4) 14A.33(3) A 5%1 A 2011 4107 14 FA 2011 3 90,000A 2011 4 12014 3 31 A 196

A B 2012 9107 14 EB 2013 7 1 100,000B 2013 7 12015 6 30 B A Belrose 2012 12Cobayer Health Food Company9 Morgan Road, Belrose, New South Wales 2085, Australia26 Belrose 197

2013 9 2Cobayer Health Food Company 6,500Belrose Cobayer Health Food Company 2013 9 12016 8 31 Cobayer Health Food Company Cobayer Health Food Company Cobayer Health Food Company A 198

61,111,100611,111,000 0.10 611,111,000 75.00% 203,800,000 H 25.00% 814,911,000 100.00% 611,111,000 72.28% 234,370,000 H 27.72% 845,481,000 100.00% HH H H 199

90% 2012 10 26 2013 10 25 H (i) HH 20% (ii)h (iii) 200

15 H HH 20% H 2013 9 3 2013 12 10 201

XV23 10% (1) (2) (3) 476,685,000 78.00% 58.50% 52,965,000 8.67% 6.50% (4) 52,965,000 8.67% 6.50% 476,685,000 78.00% 58.50% 61,111,000 10.00% 7.50% 6,599,550 1.08% 0.81% 5,498,570 0.90% 0.67% 659,340 0.11% 0.08% 659,340 0.11% 0.08% 551,480 0.09% 0.07% (1) (2) 814,911,000 (3) (4) 202

XV23 10% 203

20102011 2012 12 312013 6 30 201020112012 12 31 2013 6 30 2012 5,800 2013 6 30 49 2013 6 30 1410 2013 6 30Conbair Cokanga24231 204

20102011 2012 12 31 48.4 61.395.720102012 40.7% 16.940.8 52.620102012 76.4%20122013 6 30 38.536.6 25.545.5 1999 5 242005 5 13 2012 10 26 2010 2012 12 24Cobayer Health Food Company 205

(i) (ii) (i) (ii) (iii) 206

207

2008 2,650 2012 5,800 21.6% 201510,15014 5% 208

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%)......... 48,410 72.4 61,332 59.4 95,744 63.7 38,547 59.5 36,635 42.6....... 16,922 25.3 40,837 39.6 52,613 35.0 25,505 39.3 45,537 53.0............. 1,518 2.3 1,075 1.0 2,015 1.3 767 1.2 3,793 4.4................. 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 12 31 6 30 2010 2011 2012 2013 Q10......... 77,874 232.5 18,107 104,142 331.3 34,504 108,444 388.9 42,179 48,969 305.7 14,969... 7,909 167.8 1,327 85,112 285.3 24,280 6,208 324.4 2,014....... 7,768 32.6 253 5,340 107.5 574 32,080 625.8 20,076 7,848 941.7 7,391....... 3,115 155.2 483 25,953 183.1 4,751 19,937 176.9 3,526 30,362 311.0 9,443........... 18,843 41,156 90,061 33,817 (%).... 28.2% 39.9% 59.9% 39.3%... 5,240 313.2 1,641 27,962 274.4 7,673 73,208 306.0 22,399 28,530 473.3 13,504..... 19,340 205.8 3,980 28,611 360.4 10,311 22,819 451.9 10,312... 4,936 127.1 627 3,734 123.9 463 4,444 125.4 557 90 276.8 25..... 6,898 308.4 2,127 21,938 308.5 6,767 14,282 369.4 5,276 6,963 766.8 5,339 DHA... 34 501.9 17 9,754 456.2 4,450..... 20,538 172.0 3,533 37,365 189.4 7,076 9,139 182.0 1,662 2,473 288.1 712... 18,807 195.7 3,680 25,816 223.3 5,766 6,849 193.1 1,323 1,750 491.4 860........... 11,608 31,725 41,545 35,202 (%).... 17.4% 30.7% 27.6% 40.9%........... 30,451 72,881 131,606 69,019 (%).... 45.6% 70.6% 87.5% 80.2% 209

Q10Q10 20112010 2011 Q10Q10Q10 Q10Q10 2012 2011 Q10Q1020132012 30 Q10Q10 12090 20122011 2011 201320122013 20112010 2010 2012120 90 2012 2013 20112012 2010 2010 20132013 90 60 210

201120102012 2011 2013 20122011 2011 2013 201020112012 2013 201220132010 2011 20102011 20122013 DHA DHA 20132012 201020112012 2013 20102012 2011 2011 2013 211

2013 6 30 25 49 35142014 4572 http://conbair.tmall.com 2013 5 212

2011 Q10 Omega-32012 2013 20122013 213

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%) Q10. 18,107 27.1 34,504 33.4 42,179 28.0 16,489 25.4 14,969 17.4.... 1,327 1.3 24,280 16.1 12,623 19.5 2,014 2.3........ 253 0.4 574 0.6 20,076 13.4 5,063 7.8 7,391 8.6........ 483 0.7 4,751 4.6 3,526 2.4 1,405 2.2 9,443 11.0............ 29,567 44.2 20,176 19.5 5,683 3.8 2,967 4.6 2,818 3.3............ 48,410 72.4 61,332 59.4 95,744 63.7 38,547 59.5 36,635 42.6.... 1,641 2.5 7,673 7.4 22,399 14.9 11,279 17.4 13,504 15.7...... 3,980 3.9 10,311 6.8 6,600 10.2 10,312 12.0.... 627 0.9 463 0.4 557 0.4 128 0.2 25...... 2,127 3.2 6,767 6.6 5,276 3.5 931 1.4 5,339 6.2 DHA.... 17 4,450 5.2...... 3,533 5.3 7,076 6.9 1,662 1.1 937 1.4 712 0.8.... 3,680 5.5 5,766 5.6 1,323 0.9 622 1.0 860 1.0............ 5,314 7.9 9,112 8.8 11,068 7.4 5,008 7.7 10,335 12.1............ 16,922 25.3 40,837 39.6 52,613 35.0 25,505 39.3 45,537 53.0 (1).......... 1,518 2.3 1,075 1.0 2,015 1.3 767 1.2 3,793 4.4............ 66,850 100.0 103,244 100.0 150,372 100.0 64,819 100.0 85,965 100.0 (1) 214

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%)........ 7,111 52.3 15,220 75.8 14,941 73.7 7,437 75.3 9,158 81.3.......... 2,324 17.1 1,804 9.0 1,604 7.9 844 8.6 334 3.0........ 1,613 11.9 947 4.7 783 3.9 320 3.2 227 2.0...... 890 6.6 965 4.8 1,516 7.4 625 6.3 1,005 8.9............ 620 4.6 466 2.3 396 2.0 198 2.0 214 1.9...... 631 4.6 497 2.5 413 2.0 206 2.1 188 1.7.... 196 1.4 134 0.7 219 1.1 111 1.1 78 0.7........ 203 1.5 47 0.2 404 2.0 140 1.4 60 0.5............ 13,588 100.0 20,080 100.0 20,276 100.0 9,881 100.0 11,264 100.0 12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%)........ 7,011 51.6 6,184 30.8 6,901 34.0 2,745 27.8 3,072 27.3...... 5,352 39.4 12,989 64.7 11,831 58.4 6,596 66.8 6,826 60.6.... 1,225 9.0 907 4.5 1,544 7.6 540 5.4 1,366 12.1............ 13,588 100.0 20,080 100.0 20,276 100.0 9,881 100.0 11,264 100.0 215

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%)........... 41,399 77.7 55,147 66.3 88,843 68.3 35,802 65.2 33,563 45.0......... 11,570 21.7 27,849 33.5 40,782 31.3 18,909 34.4 38,711 51.8................... 293 0.6 168 0.2 471 0.4 227 0.4 2,427 3.2................... 53,262 100.0 83,164 100.0 130,096 100.0 54,938 100.0 74,701 100.0 12 31 6 30 2010 2011 2012 2012 2013........... 85.5% 89.9% 92.8% 92.9% 91.6%......... 68.4% 68.2% 77.5% 74.1% 85.0%................... 79.7% 80.6% 86.5% 84.8% 86.9% 2011 12 312013 6 309.022.0 4.35% 5.4% 216

20102011 2007 2012 2009 201020112012 12 3120122013 6 30 0.70.3 1.50.40.62012 12 31 12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%).... 8,786 46.9 7,307 35.9 8,397 24.7 3,524 30.3 5,748 25.9.... 6,806 36.3 9,035 44.4 17,212 50.6 5,319 45.8 11,265 50.7........ 892 4.8 847 4.2 1,895 5.6 1,055 9.1 1,658 7.5.. 1,474 7.9 2,154 10.6 3,403 10.0 1,075 9.2 1,569 7.1........ 634 3.4 672 3.3 1,716 5.0 562 4.8 928 4.2............ 140 0.7 324 1.6 1,424 4.1 91 0.8 1,048 4.6............ 18,732 100.0 20,339 100.0 34,047 100.0 11,626 100.0 22,216 100.0 217

12 31 6 30 2010 2011 2012 2012 2013 (%) (%) (%) (%) (%).... 5,302 37.3 5,940 37.2 9,889 47.9 4,793 51.5 5,550 43.4.. 3,131 22.0 3,925 24.6 4,039 19.6 1,710 18.3 1,766 13.8........ 2,005 14.1 1,596 10.0 1,735 8.4 771 8.3 873 6.8...... 1,749 12.4 1,791 11.3 1,751 8.5 886 9.5 1,259 9.9.. 1,673 11.7 2,479 15.5 2,988 14.5 1,066 11.4 919 7.2........ 354 2.5 224 1.4 219 1.1 89 1.0 383 3.0........ 2,038 15.9............ 14,214 100.0 15,955 100.0 20,621 100.0 9,315 100.0 12,788 100.0 25.0% Cobayer Health Food Company30% 218

201020112012 12 3120122013 6 30 12 31 6 30 2010 2011 2012 2012 2013....................... 66,850 103,244 150,372 64,819 85,965..................... (13,588) (20,080) (20,276) (9,881) (11,264)......................... 53,262 83,164 130,096 54,938 74,701................. 679 337 1,484 436 581............... (18,732) (20,339) (34,047) (11,626) (22,216)..................... (14,214) (15,955) (20,621) (9,315) (12,788)............... 20,995 47,207 76,912 34,433 40,278................... (5,207) (12,393) (19,675) (8,265) (10,578)................. 15,788 34,814 57,237 26,168 29,700........ 75 (108) (11) (412)......... 15,863 34,706 57,226 26,168 29,288............... 0.29 0.63 1.04 0.48 0.53 219

2013 6 302012 6 30 2012 6 30 64.8 21.2 32.7%2013 6 30 86.0 2012 6 30 25.520.0 78.4%2013 6 30 45.5 2012 6 302013 6 30 11.3 13.5 6.6 10.3 0.9 5.3 2013 2013 2012 6 30 38.51.9 4.9%2013 6 30 36.6 2012 6 302013 6 30 12.6 2.0 Q1016.5 15.02013 220

2012 6 30 1.42013 6 30 9.4 20132013 2012 6 30 0.83.0 3.82013 6 30 3.8 2012 6 30 9.9 1.4 14.1%2013 6 30 11.3 2012 6 302013 6 30 2.70.414.8% 3.1 2013 2012 6 30 6.60.23.0%2013 6 30 6.8 2012 6 30 0.50.9 1.82013 6 30 1.4 2012 6 30 54.9 19.8 36.1%2013 6 30 74.7 2012 6 3084.8% 2013 6 30 86.9% 221

2012 6 30 35.8 2.2 6.1%2013 6 30 33.6 2012 6 3092.9%2013 6 30 91.6% 2013 2012 6 30 18.919.8 104.8%2013 6 30 38.72012 6 30 74.1% 2013 6 3085.0% 2013 2012 6 30 0.4 0.2 50.0%2013 6 30 0.6 2012 6 30 11.6 10.6 91.4%2013 6 30 22.2 2013 2012 6 30 9.33.5 37.6%2013 6 30 12.8 2012 6 30 34.45.9 17.2%2013 6 30 40.3 222

2012 6 30 8.32.3 27.7%2013 6 30 10.6 2012 6 30 24.0% 2013 6 3026.3%2013 2012 6 30 26.2 3.5 13.4%2013 6 30 29.7 2012 12 312011 12 31 2011 103.247.2 45.7% 2012 150.4 2011 61.3 34.4 56.1% 2012 95.7 20112012Q1034.5 42.2 1.3 24.3 0.6 20.1 2011 2012 2012 223

2011 40.811.8 28.9% 2012 52.6 20112012 7.7 22.4 4.0 10.3 2011 7.12012 1.7 2012 2012 2011 2012 6 2012 12 31 2011 1.1 0.9 81.8% 2012 2.0 2011 2011 20.10.2 1.0% 2012 20.3 2011 6.2 0.711.3%2012 6.9 56.1% 224

2011 13.0 1.2 9.2% 2012 11.8 (i) 2011 (ii) 2011 0.90.6 66.7% 2012 1.5 2011 83.246.9 56.4% 2012 130.1201180.6% 201286.5% 2011 55.133.7 61.2% 2012 88.8201189.9% 201292.8% 2011 27.813.0 46.8% 2012 40.8201168.2% 201277.5%(i) 2011 (ii) 2011 0.31.2 4.02012 1.5 2011 225

2011 20.313.7 67.5% 2012 34.0 2011 16.04.6 28.8% 2012 20.6 2011 47.2 29.7 62.9% 2012 76.9 2011 12.47.3 58.9% 2012 19.7 201126.3%201225.6% 2011 34.822.4 64.4% 2012 57.2 226

2011 12 312010 12 31 2010 66.936.3 54.3% 2011 103.2 2010 48.4 12.9 26.7% 2011 61.3 20102011Q10 18.1 34.5 1.3 0.3 0.6 2011Q102011 2011 2010 16.923.9 141.4% 2011 40.8 2010 1.62011 7.7 2011 Omega-3 2010 1.5 0.4 26.7% 2011 1.1 227

2010 13.66.5 47.8% 2011 20.1 2010 7.0 0.8 11.4% 2011 6.2 2010 5.4 7.6 140.7% 2011 13.0 2011 2010 1.20.3 25.0% 2011 0.9 2010 53.329.9 56.1% 2011 83.2201079.7% 201180.6% 2010 41.413.7 33.1% 2011 55.1201085.5% 201189.9%Q10 2010 11.616.2 139.7% 2011 27.8 201068.4%201168.2% 228

2010 0.70.4 57.1% 2011 0.32010 0.52011 2011 2010 2010 18.71.6 8.6% 2011 20.3 2010 14.21.8 12.7% 2011 16.0 2010 21.0 26.2 124.8% 2011 47.2 2010 5.27.2 138.5% 2011 12.4 201024.8%201126.3% 2010 15.819.0 120.3% 2011 34.8 229

12 31 6 30 2010 2011 2012 2012 2013.......... 17,347 35,181 57,923 31,058 35,396............... (124) (8,835) 4,670 8,092 (23,937)............... (12,836) 340 (32,307) (2,252) 24,486........ 4,387 26,686 30,286 36,898 35,945........ 31,638 36,306 62,775 62,775 93,220.............. 281 (217) 159 43 (782)........ 36,306 62,775 93,220 99,716 128,383 230

2013 6 3035.4 41.33.7 9.20.6 201257.9 77.72.9 1.420.5 2.7 201135.2 49.14.4 10.35.5 2.8 201017.3 23.03.9 0.8 2013 6 3023.9 22.0 2.40.4 20124.7 9.01.3 0.6 3.8 2.4 231

20118.8 9.00.4 20100.1 0.60.4 2013 6 3024.5 50.0 0.5 26.0 201232.3 35.0Cobayer Health Food Company 4.1 6.2 0.6 20110.3 0.3 201012.8 6.0 5.11.8 232

12 31 6 30 2010 2011 2012 2012 2013.... 550 246 2,390 1,271 2,364.... 3,795.... 552......................... 550 246 6,737 1,271 2,364 2014 12 31 12 233

12 31 6 30 10 31 2010 2011 2012 2013 2013...................... 5,438 10,944 13,684 9,962 8,093........... 101 101 101 101 101......... 3,446 5,989 3,731 4,188 7,397.............. 256 271 691............ 423 478.................. 9,000 22,000............ 36,306 62,775 93,220 128,383 140,641.............. 45,970 89,558 111,427 164,634 156,232......... 4,410 8,614 10,037 10,021 10,311........... 2,741 2,957 3,983 3,303............ 266................ 3,369 6,866 6,098 7,003 3,293.............. 10,520 18,703 20,118 20,327 13,604.............. 35,450 70,855 91,309 144,307 142,628 234

12 31 6 30 2010 2011 2012 2013................. 1,016 564 639 579................. 13 9 172 189................. 722 964 887 631................. 3,687 9,407 11,986 8,563................... 5,438 10,944 13,684 9,962 2010 12 31 5.42011 12 31 10.92012 12 31 13.7 2012 12 31 13.72013 6 30 10.0 2013 12 31 6 30 2010 2011 2012 2013 (1)...... 146.6 148.9 221.7 191.6 (1) 235

20102011 2011148.92012221.72012 2011 2013 6 30 191.6 (i) (ii) (iii) (iv) 12 31 6 30 2010 2011 2012 2013........... 545 303 474 339........... (179)................... 366 303 474 339........... 314 223 283 317......... 2,766 5,463 2,974 3,532................... 3,446 5,989 3,731 4,188 2010 12 31 3.42011 12 31 6.02012 12 313.7 2011 2012 12 31 3.72013 6 30 4.2 236

12 31 6 30 2010 2011 2012 2013 1.......... 42 120 165 207 1 3........... 3 296 127 3 1..... 164 40 9 5 1............ 157 143 4................... 366 303 474 339 2010 12 31 0.2 21 12 31 6 30 2010 2011 2012 2013 (1)............ 2 1 1 1 (1) 237

2010220112012 2013 6 301 30 2012 6 2010 2011 12 31158 12 31 6 30 2010 2011 2012 2013........... 1,209 580 885 1,197..... 3,201 8,034 9,152 8,824................... 4,410 8,614 10,037 10,021 2013 6 302012 12 31 2011 12 31 8.62012 12 31 10.0 2010 12 31 4.42011 12 31 8.6 2011 2011 238

12 31 6 30 2010 2011 2012 2013 1............ 715 15 230 107 13........ 6 89 443 874 312....... 459 93 86 3 12........... 29 383 126 213................... 1,209 580 885 1,197 12 31 6 30 2010 2011 2012 2013 (1)............ 39 16 13 17 (1) 239

2013 6 30 2013 6 30 2013 10 31...................................... 9,962 4,248............................ 339 330 (1)........................... 3,849 2,308...................................... 4,188 2,638 (1) 201020112012 12 310.3 0.30.7 2013 6 30 201020112012 12 312013 6 30 2.73.04.03.3 2013 9 240

201020112012 12 312013 6 302013 10 31 2013 10 31 201020112012 12 312013 6 30 12 31 6 30 2010 2011 2012 2013 1.................. 593 437 494 1,497 1 5................. 495 993................... 593 437 989 2,490 201020112012 12 312013 6 30 241

2013 10 31 242

20142016 5% 243

201020112012 12 31 2013 6 306.0 35.026.0 30% H 2013 6 30 66.7 2013 6 302.0 2013 6 302013 6 30 31.713.8 17.9 244

6 30 12 31 12 31 6 30 2010 2011 2012 2013.......... (1) 4.4 4.8 5.5 8.1.......... (2) 3.9 4.2 4.9 7.6...... (3)...... (4)........ (5) (1) = (2) = (3) = (4) = (5) = 201020112012 12 312013 6 30 4.4 4.8 5.5 8.1 201020112012 12 312013 6 30 3.9 4.2 4.9 7.6 245

2013 12 31 2013 6 30 2013 6 30 13.8 2013 12 31 13.13 13.1913.13 13.19 2013 9 30 2013 6 30 2013 9 30 2013 6 30 (1)................ 22,693................................................ (331) 2013 9 30................................ 22,362............................................ 23,738 2013 9 30........ 46,100 (1) 246

2013 6 30 2013 6 30 (1) (2) (3) 1.50....... 172,736 224,879 397,615 0.49 0.62 2.00....... 172,736 301,595 474,331 0.58 0.74 1. 2013 6 30 2013 6 30172,801,000 65,000 2. 1.502.00 0.78841.00 3. 814,911,000 203,800,0001.502.00 4. 0.78841.00 2013 12 16 5. 2013 6 30 247

H 1.75 333.9 H 1.75 51.1 H 2.00 48.7 H 1.50 48.7 43%143.6 31%103.6 800,000650,0002,000,000 6%20.0 6%20.0 34%113.5 23%76.8 248

6%20.0 3%10.0 2%6.7 Q10 Q10 18%60.1 6%20.02014 2014 4572 12%40.120152016 201520162080 5%16.7 249

15 250

5.038.8 H 2,000 HH 1.50 H25,844,000 (i)12.7%(ii) 3.2%(iii) 3.1% H 1.75 H22,152,000(i)10.9% (ii)2.7% (iii) 2.6%H 2.00 H 19,382,000(i)9.5%(ii) 2.4%(iii) 2.3% 2004 3886 65 H 251

2014 1 14 (a) (b) HH (c) (d) H H 252

H 8 (a) (i) 253

(ii) (iii) (iv) (v) (vi) 254

(vii) (viii) (ix) (x) (xi) (xii) (xiii) (xiv) (xv) H H (xvi) H (xvii) 255

(xviii) (1) (2) (3) (4) (b) (i) 256

(ii) (iii) (iv) (v) (vi) (vii) (viii) 257

(ix) H H (x) 10.08H 10.07 (a) H (b) (a) (a) 258

12 (a) 155 (b) (a) 259

(b) (c) (a) (b) (d) (a) (b) (c) (a) (b) (c) (a) (b) (c) (a) (i) 260

(ii) (iii) (i) (ii) (iv) (i) (ii) (iii) (i) (ii) (iii) (b) (a)(i) (ii) (iii) (c) (a)(i) (ii) (iii) 261

3.5% 1.0% 1.75 42.8 8.08 25% 30 30,570,000 H 15%H 262

H 30 2014 2 730 263

(i) H H (ii) (i) (A) (1) H (2) H (B) H (ii)(a) (C) (i) H (D) (ii)(a) (ii)(b) (ii)(c) H H H H 30 571W 93 H H H 264

H 571W 3A.07 265

(i) 20,380,000 H 10% (ii) S183,420,000 H 90% 2.001.50 2.00 2.00 13. 266

H H 2014 1 8 2014 1 9 2014 1 13H 2014 1 13 8.05(2)(d) www.hkexnews.hk www.zs-united.com 267

H H H H 2014 1 14 11. H H 268

30 13. 155 (i)(ii) H2014 1 142014 1 15 8 20,380,000 H 203,800,000 H10% 2.5% 269

5 5 10,190,000 50% H H H H 270

184.2 H H H H1550 H 61,140,000 H30% H H50100 H 81,520,000 H40% H H100 H 101,900,000 H50% H 271

183,420,000 H H 90% 22.5% S 30 30,570,000 H 15%HH H H H H H 2014 1 158 H2014 1 159 H 2,000 H 272

1. eipowww.eipo.com.hk eipo 2. 18 S eipo (i)(ii) eipo 273

3. (a) www.eipo.com.hkeipo (b) 2013 12 3192014 1 8 12 (i) 68 9 189 1 29 18-19 274

(ii) 20 368 678 A B 136 127-129 328 G9B-G11 29-35 1 2013 12 3192014 1 8 12 1992 275

(vi) (vii) (viii) H (ix) (x) (xi) (xii) (i) (ii) SS902(h)(3) (xiii) (xiv) (xv) H H 277

(xvi) (xvii) (xviii) eipo (xix) (i) (ii) 5. eipo (a) 2. www.eipo.com.hkeipo eipo eipo eipo (b) eipo 2013 12 3192014 1 8 11 3024www.eipo.com.hk 278

eipo 2014 1 81210. (c) eipo eipo eipo eipo (d) 40 40 342E (e) eipo eipo www.eipo.com.hkeipo 6. (a) 279

2979 7888 https://ip.ccass.com 199 2 H (b) (i) (ii) 280

H H 281

40 282

(e) 2013 12 31 9 8 30 (1) 2014 1 2 8 8 30 (1) 2014 1 3 8 8 30 (1) 2014 1 4 8 1 (1) 2014 1 6 8 8 30 (1) 2014 1 7 8 8 30 (1) 2014 1 8 8 (1) 12 (1) 2013 12 319 2014 1 812 24 2014 1 8 12 (f) (g) 40 40 342E 284

HIP1307002_C_Project Energy 2013()_.indb